Nephrocare Health Services valuation

Share price at each year-end
Tap a line for its trendCurrentlast closeFY26Mar 2026
Price multiples — at each FY-end close
82.06×—
5.65×—
6.31×—
55.69×—
Enterprise multiples
6.10×—
26.83×—
44.69×—
Yield
1.2%—
1.8%—
Reference — adjusted share basis
₹628.40—
₹7.66₹7.66
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

NEPHROPLUS₹628.40

Nephrocare Health Services Limited

· Pharma & Health
₹ CrorePeersKRSNAASURAKSHAHEALTHX3BBLACKBIOMcap ₹6,305 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
Multiples — ₹ Crore base
12 Months Ending
FY26
31/03/2026
Current
last close
Price Multiples — at each FY-end close
P/E—82.06
P/B—5.65
P/Sales—6.31
Price to Free Cash Flow—55.69
Enterprise Multiples
EV/Sales—6.10
EV/EBITDA—26.83
EV/EBIT—44.69
Yield
Earnings Yield %—1.22
FCF Yield %—1.80
Reference — adjusted share basis
Price (FY-end close, adj.)—628.40
EPS (adj.)7.667.66
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.